TY - JOUR A1 - Ibikunle, Adebayo A1 - Taiwo, Abdurazzaq A1 - Braimah, Ramat A1 - Adeyemi, Michael A1 - Abdullahi, K A1 - Sahabi, Saddiku T1 - Ameloblastoma: Clinicopathologic and therapeutic analysis of 67 cases seen at Usmanu Danfodiyo University Teaching Hospital Sokoto, Nigeria Y1 - 2018/10/1 JF - International Journal of Health & Allied Sciences JO - Int J Health Allied Sci SP - 240 EP - 245 VL - 7 IS - 4 UR - https://www.ijhas.in/article.asp?issn=2278-344X;year=2018;volume=7;issue=4;spage=240;epage=245;aulast=Ibikunle DO - 10.4103/ijhas.IJHAS_39_18 N2 - INTRODUCTION: Ameloblastoma is a benign odontogenic neoplasm which is slow growing, locally aggressive, and has a potential for recurrence. Recurrence rates as high as 75% have been reported. If unattended to, it results in large grotesque maxillofacial growths with consequent impairment of function and esthetics. This study aims to report the clinicopathologic and surgical outcome of patients managed on account of ameloblastoma at a Nigerian teaching hospital. MATERIALS AND METHODS: Records of patients histologically diagnosed with ameloblastoma of the jaws between March 2010 and March 2017 at Usmanu Danfodiyo University Teaching Hospital were retrieved. Information on biodata, clinic-pathologic features, treatment modality, mode of reconstruction, postsurgical follow-up period, and recurrence was obtained. RESULTS: A total of 67 patients were included in this study, including 41 (61.2%) males and 26 (38.8%) females; with a mean age (± standard deviation) of 31.43 (±13.65) years. The modal decade of presentation was the third decade of life. Majority of the tumors were right sided 27 (40.3%). Fifty-six (83.6%) of the cases were seen in the mandible, while 11 (16.4%) occurred in the maxilla. Majority of the tumors were multilocular 62 (92.5%). All the unilocular radiolucencies were seen among patients younger than 23 years of age. The most frequently observed histological subtype was the follicular type 26 (38.8%); rare mixed lesions were also seen. Immediate reconstruction was performed in most of the patients. Recurrence was observed in 1 case (1.5%). CONCLUSION: Ameloblastoma remains a prominent health challenge in our climes. Patients often present late resulting in large maxillofacial tumors that are challenging to manage. ER -